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3 Background MicroRNAs (miRNAs) have attracted attention in basic pain research due to their dysregulation in chronic pain states (Elramah et al., 2014; Kress et al., 2013; Zhao et al., 2010) . This class of small non-coding RNA molecules modulates gene expression by posttranscriptional silencing of target mRNAs (Bartel, 2004) . Differential expression of proteins and altered gene regulation may arise as a consequence of neuropathic pain (Costigan et al., 2009 ) which results from a lesion or dysfunction affecting the somatosensory system (Treede et al., 2008) . To this day, for most individual miRNAs, their roles in specific gene regulation in the context of chronic pain remain elusive.
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family (Huang and Reichardt, 2003) . The protein is critically involved in pathological nociceptive processes such as neuropathic pain (Coull et al., 2005) . It has been demonstrated previously that microRNA-1 (miR-1) negatively regulates BDNF expression by directly targeting the 3` untranslated region (UTR) of Bdnf mRNA (Brandenburger et al., 2014; Varendi et al., 2014) .
Important insights in understanding Bdnf gene function in nociception were provided by studies using various transgenic knockout mice (MacQueen et al., 2001; Zhao et al., 2006) .
Whether gene deletion in transgenic mice in general has an impact on corresponding miRNAs is completely unknown. In this study we asked whether neuron-specific deletion of BDNF in DRG affects its interaction with miR-1.
To address this question, we used DRG neuron-specific, tamoxifen-inducible adult Bdnf conditional knockout mice (Bdnf fl/fl ;Advillin-CreER T2 ) with an early (on day 10) and late (on day 32) time point after completion of tamoxifen induction treatment. This tissue-specific gene deletion was achieved by crossing Bdnf fl/fl mice that carried a loxP-flanked Bdnf gene with Bdnf fl/fl ;Advillin-CreER T2 mice expressing the Cre recombinase driven by the promotor of Advillin gene, which is a peripheral sensory neuron-specific marker. It is important to note
4 that Advillin-CreER T2 transgenic mice showed no neuronal cell loss and displayed a normal phenotype in various pain models (Lau et al., 2011) . We hypothesize a positive regulatory loop from BDNF protein towards miR-1 suggesting this feedback mechanism being altered in an inducible BDNF knockout mouse strain. Thus, we asked whether Bdnf gene deletion affects the positive feedback loop resulting in an altered miR-1 expression. In addition, there is evidence that miR-1 negatively regulates heat shock protein 60 (Hsp60) (Pan et al., 2012; Shan et al., 2010) and connexin 43 (Cx43) (Yang et al., 2007) . Interestingly, both proteins are linked to neuropathic pain (Chen et al., 2012; Mor et al., 2011) . Recently, we reported that neuropathic pain in rats with chronic-constriction injury is associated with reduced expression of miR-1 and increased levels of Cx43 protein in the injured sciatic nerve (Neumann et al., 2015) . Hsp60 was additionally reported to play an important role in neurodegeneration (Lehnardt et al., 2008) and was identified among a group of axonally synthesized proteins in cultures of injury-conditioned adult dorsal root ganglion (DRG) neurons (Willis et al., 2005) .
Consequently, we analyzed the expression of Hsp60 and Cx43 in Bdnf cKO mice. Finally, we investigated whether transcriptional regulation has an impact on miR-1 and Bdnf gene expression by analyzing the expression of serum response factor (SRF) and myocyte enhancer factor 2 (MEF2a). Both transcription factors have been described to regulate expression of miR-1 (Chen et al., 2006; Simon et al., 2008; Zhao et al., 2005) .
In this study, we focus on miR-1 and its interaction with BDNF suggesting their integration in a regulatory positive feedback mechanism. At an early time point after Bdnf gene deletion this positive regulatory loop seems to be interrupted resulting in a downregulation of miR-1.
Hence, we decribe the impact of the suppressed miRNA expression on its downstream targets Hsp60 and Cx43, which are both associated with neuropathic pain. Finally, we study possible prolongation of changes in expression levels at a later time point after Bdnf gene deletion and provide additional information on further dysregulated miRNAs in these animals. 

Expression analysis of miRNAs in DRG of
Bdnf cKO mice at a late time point after Bdnf gene deletion using microRNA microarray
As described above, expression analyses did not show a significant regulation of miR-1, Hsp60 protein and Cx43 protein in Bdnf cKO mice at a late time point after Bdnf gene deletion. We extended our analysis to further investigate whether miRNA-associated effects are exclusive to Bdnf cKO mice at an early stage after Bdnf gene deletion. Using miRNA microarray analysis we detected a total of 167 significantly (p < 0.05) modified mature miRNAs in DRG of Bdnf cKO mice on day 32 after Bdnf gene deletion ( Figure 7A ) including 54 miRNAs with an expression change of a minimum of 20% ( Figure 7B ). A fraction of 16 of these 54 miRNA alterations were found to be higly significant (p < 0.01). While the expression level of miR-1a-3p, which directly targets the 3` UTR of Bdnf mRNA, was not altered (relative expression 1.10 vs. WT; p = 0.55) the expression level of miR-1b-3p, which
is not known to be involved in BDNF regulation was reduced to 0.80-fold (p<0.01).
Furthermore, we identified the bioinformatically predicted Cx43-linked miR-30f (www.targetscan.org), which was upregulated to 1.21-fold (p < 0.05).
Discussion
In this study we present essential effects of Bdnf gene deletion in DRG neurons on miRNAs, in particular on expression levels of miR-1 and its downstream targets. For this purpose we have employed DRG-specific and tamoxifen-inducible adult Bdnf cKO mice which yield an attractive approach to investigate BDNF function in pain pathways including neuropathic pain. These DRG-specific conditional BDNF-deficient mice were generated by crossing Bdnf fl/fl mice with Advillin-CreER T2 mice expressing tamoxifen-inducible Cre recombinase driven by Advillin promotor. Importantly, the pain phenotype of the Advillin-CreER T2 mice was normal (Lau et al., 2011) . We showed that Bdnf gene deletion was restricted to DRG.
Bdnf gene expression levels remained unchanged in sciatic nerve and spinal cord tissue. In line with these findings, Advillin gene expression studies by Northern blot analyses and in situ hybridization (Marks et al., 1998) and further histological analyses (Hasegawa et al., 2007 ) revealed a strong expression and staining, respectively of the promotor in particular in DRG.
Since Bdnf gene expression seems to be regulated by specific miRNAs loss of this neurotrophic factor prompts the question of unforeseen miRNA changes in ablation of Bdnf in the mutant mice. To address this issue, we focused on miR-1 which was previously detected in mouse DRG and localized in sensory neurons (Bastian et al., 2011) . Secondly, it has been reported that miR-1 is dysregulated in mouse DRG in different pain states (Kusuda et al., 2011) . Thirdly, miR-1 negatively modulates Bdnf gene expression (Brandenburger et al., 2014; Varendi et al., 2014) and inhibits expression of the neuropathic pain-associated proteins Hsp60 and Cx43 (Pan et al., 2012; Shan et al., 2010; Yang et al., 2007) . To regulate specific
genes, recent studies implicate that microRNAs even participate in feedback or feed forward mechanisms (Tsang et al., 2007) . Chen and colleagues identified a negative feedback model in which miR-1 is incorporated to control skeletal muscle gene expression (Chen et al., 2006) . In terms of miR-1 and BDNF, we hypothesize a positive regulatory loop from BDNF towards miR-1 ( Figure 8A ) suggesting this feedback mechanism becoming interrupted with the loss of BDNF in Bdnf cKO mice ( Figure 8B ).
In the present study, we first investigated animals at an early time point after Bdnf gene deletion (10 days after the last tamoxifen treatment) and found a remarkable downregulation of miR-1 in DRG compared to WT controls. The altered miR-1 expression may be a consequence of a disturbed positive regulatory loop in conditional Bdnf cKO mice. Given that transcriptional regulation processes are essential for gene activation, inhibition and expression including miRNA expression (Guo et al., 2014; Hobert, 2008) we analyzed the transcriptional factors MEF2a and SRF. Feedback loops between MEF2/SRF and miR-1 have been described earlier (Chen et al., 2006; Zhao et al., 2005) and both proteins are key regulators of neuronal differentiation and mediate growth factor-related functions (Knöll and Nordheim, 2009; Lin et al., 1996) . Nonetheless, MEF2a and SRF do not seem to be involved in controlling the interaction between miR-1 and BDNF in Bdnf cKO mice at an early time point after Bdnf gene deletion. However, we reasoned that the suppressed miR-1 might have an impact on its downstream targets Hsp60 and Cx43. Western blot analyses showed an almost twofold increase of Hsp60 expression in DRG of Bdnf cKO animals. The Hsp60 data indicate protein induction resulting from diminished posttranscriptional inhibition due to reduced expression of miR-1. In contrast to that finding, no Cx43 expression changes could be determined. It is tempting to speculate that the discrepancy between Hsp60 and Cx43 data may result from a more complex Cx43 gene structure and regulation (Pfeifer et al., 2004) .
Not only the length of mouse Cx43 3` UTR is 1706 nucleotides, but there are 21 bioinformatically predicted miRNA families, which are supposed to interact with Cx43
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
10
(www.targetscan.org), including miR-30f, which we found to be increased in DRG at the later timepoint after Bdnf gene deletion. By contrast, the length of mouse Hsp60 3` UTR is considerably shorter (462 nucleotides). In addition to the miR-1-3p/206/613 family, Hsp60 is predicted to be regulated by eleven other miRNA families conserved in all vertebrates (www.targetscan.org). However, from these only miR-140-3p was detected by the performed miRNA microarray to be affected with a reduced expression in DRG of Bdnf cKO animals (ratio 0.60; p < 0.01), a modification that may contribute to increased expression of Hsp60.
Since the first set of experiments was based on an early time point after Bdnf gene targeting we asked whether the dysregulation of miR-1 and Hsp60 in DRG was permanent. Therefore, we analyzed Bdnf cKO mice 32 days after completion of tamoxifen injections. At this later time point only minor and non-significant alterations of miR-1 and Hsp60 were observed.
Cx43 expression remained unmodified. However, these results can not rule out long-lasting miR dysregulation. To clarify whether miRNA dysregulations after Bdnf gene deletion are temporary and can therefore be generally prevented by investigating Bdnf cKO mice only at a later timepoint after induction of gene deletion, we performed a global miRNA microarray expression analysis. This analysis revealed a total of 167 significant differentially expressed miRNAs in Bdnf cKO mice on day 32 after completed tamoxifen injection providing two pieces of important information. Firstly, the bioinformatically predicted Cx43-associated mir30f miRNA was significantly upregulated to 1.2-fold. Secondly, microarray analyses revealed a large number of misexpressed miRNAs with other targets than BDNF, Hsp60 or Cx43.
Hence, DRG-specific Bdnf gene deletion in Bdnf cKO mice does not lead to permanent dysregulation of the BDNF-targeting miRNA miR-1 and its other targets Hsp60 and Cx43 but seems to be sensitive to significant alteration of various other microRNAs.
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Conclusion
In summary, we found a significant downregulation of miR-1 in DRG 10 days after Bdnf gene deletion induced by tamoxifen treatment in Bdnf cKO mice, which appears to be MEF2a-/SRF-independent, as well as an upregulation of the neuropathic pain-associated protein Hsp60. We presume a previously unkown feedback mechanism between a manipulated gene (Bdnf) and its regulating miRNA (miR-1) affecting its downstream target (Hsp60) in an early inducible Bdnf cKO. Here, the lack of a protein that serves essential functions in somatosensation may contribute to a specific miRNA-mediated abnormal pain phenotype.
These miR-1-associated effects could not be confirmed in Bdnf cKO mice at a later timepoint after Bdnf gene deletion and thus may be transient, although permanent miR dysregulation cannot be excluded. Even at a later timepoint after Bdnf gene deletion, BDNF proteindeficiency still appears to trigger misexpression of multiple other miRNAs. Given the importance of understanding Bdnf gene function in chronic pain conditions by using conditional BDNF knockout, miRNA-associated effects occuring irrespective of the specific targeted gene may be important to consider.
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Methods
Animals
All tests were approved by the United Kingdom Home Office Animals (Scientific Procedures) Act 1986. Experiments were conducted using at least 6 weeks old mice of both sexes and identical genetic background (C57BL6/J). The same observer performed all experiments and was blind to the genotype of the animals.
Generation of Bdnf cKO transgenic mice
Transgenic Bdnf fl/fl mice carrying loxP sites flanking the exons 5 in the Bdnf gene were interbred with Advillin-CreER T2 mice expressing a tamoxifen-inducible modified Cre recombinase under the control of the DRG neuron-specific advillin promoter (Lau et al., 2011 ) to obtain Bdnf fl/fl ;Advillin-CreER T2 mice. Genotyping of mice for Bdnf fl/fl and Cre was performed by standard PCR as previously described (Lau et al., 2011; Zhao et al., 2006) .
Mice carrying Bdnf fl/fl and Advillin-CreER T2 are referred to as 'Bdnf cKO mice', the respective Bdnf fl/fl ;Cre-null mice are called 'WT mice', as they are phenotypically normal. To delete the Bdnf gene, the Bdnf cKO and WT control mice were treated with tamoxifen at the age of 8-12 weeks as described (Lau et al., 2011) . Mice were housed with a 12-hr light/dark cycle and maintained under standard condition (21 ± 1°C, food and water ad libitum). A fiveday treatment with tamoxifen (2 mg per day; intraperitoneal injection) induced a highly specific recombinase activity, which was confined to sensory neurons. The resulting transgenic mice were healthy with no sensory neuron loss. Animals with early and late BDNF gene targeting (10 days and 32 days after induction) and floxed BDNF control littermates were used for the present study.
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RNA isolation
Total RNA of sciatic nerve, dorsal root ganglia and spinal cord tissue was isolated using
Trizol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer`s protocol. RNA integrity was verified by Agilent microfluid chips using an Agilent 2100 Bioanalyzer (Agilent, USA). All samples in this study showed high quality RNA Integrity Numbers (RIN varied between 7.0 and 7.6). RNA was further analyzed by UV spectrophotometry (Nanodrop, Thermo Scientific, USA) and quantified by a fluorimetric Qubit RNA assay (Invitrogen).
Microarray based microRNA expression analysis
Biotin labeling of four biological replicates per genotype was performed according to the manufacturer´s protocol (FlashTag Biotin HSR RNA Labeling Kit, Affymetrix, Inc.). Briefly, 250 ng of total RNA were ligated to biotin labeled DNA dendrimers after poly(A) tailing.
Labeled RNA was hybridized to Affymetrix miRNA 4.0 Microarrays for 18h at 48 °C, stained by strepatavidin/phycoerythrin conjugate and scanned as described in the manufacturer´s protocol. Data analyses on Affymetrix CEL files were conducted with Partek Genomics Suite software (vers. 6.6; Partek, Inc.). Probes within each probeset were summarized by means of robust multi-array average algorithm after quantile normalization of probe level signal intensities across all samples to reduce inter-array variability (Bolstad et al., 2003) . 
Real-time Quantitative
BDNF ELISA
BDNF protein levels of DRG were analyzed using the BDNF Emax® ImmunoAssay System (Promega, Madison, Wisconsin). Protein isolation was performed as described above.
According to the manufacturer's protocol, ninety-six-well plates were coated with anti-BDNF monoclonal antibody and buffer (0.025M sodium bicarbonate and 0.025M sodium carbonate adjusted to pH 9.7) and incubated at 4 °C overnight. The plates were washed with TBS-T and incubated with 200 μl of Block and Sample buffer (BDNF E max ™ ImmunoAssay System, Promega, Madison, WI, USA) for 1 h at room temperature before samples were added.
Briefly, 100 μl of each sample and BDNF standards were transferred to the ELISA plate, shaked for 2 h followed by incubation with anti-human BDNF polyclonal antibody and antiIgG antibody conjugated to horseradish peroxidase. The color reaction was stopped with 1 M HCl and the absorbance was measured at 450 nm. BDNF levels were calculated from the standard curve prepared for each plate and normalized to the concentration of total protein in each sample. The standard curves were linear within the range used (0-500 pg/ml).
Statistics
Results are expressed as mean ± SEM and analyzed by student's t test or oneway-ANOVA using GraphPad Prism Software version 6 (San Diego California USA) or Partek Genomics Suite software (vers. 6.6; Partek, Inc.), respectively. The significance threshold was set to p < 0.05. 
